UK - Piramal Critical Care
  • News & Events
  • Contact & Support
  • Careers
  • UK

  • Global

    CIS

    • Armenia
    • Azerbaijan
    • Belarus
    • Bosnia
    • Estonia
    • Georgia
    • Kyrgystan
    • Latvia
    • Lithuania
    • Moldova
    • Romania
    • Russia
    • Slovenia
    • Tajikistan
    • Turkmenistan
    • Ukraine
    • Uzbekistan

    North America

    • Canada
    • United States

    South America

    • South America

    Europe

    • Austria
    • Belgium
    • Bulgaria
    • Croatia
    • Cyprus
    • Czech Republic
    • Denmark
    • Finland
    • France
    • Germany
    • Greece
    • Hungary
    • Iceland
    • Ireland
    • Israel
    • Italy
    • Malta
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Serbia & Montenegro
    • Slovakia
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Kingdom

    Middle East

    • Bahrain
    • Egypt
    • Iran
    • Iraq
    • Jordan
    • Kuwait
    • Lebanon
    • Oman
    • Palestine
    • Qatar
    • Saudi Arabia
    • Syria
    • United Arab Emirates (UAE)

    Africa

    • North Africa
    • South Africa
    • East Africa
    • West Africa

    Asia Pacific

    • Australia
    • Bangladesh
    • Bhutan
    • China
    • Hong Kong
    • India
    • Indonesia
    • Japan
    • Korea
    • Malaysia
    • New Zealand
    • Philippines
    • Taiwan
    • Thailand
    • Vietnam
    • Singapore
    • Myanmar
    • Mongolia
    • Papua New Guinea
    • Cambodia
Skip to content
  • Home
  • About
    • Our Story
    • Management Team
    • Manufacturing Facilities
    • Corporate Responsibility
    • Environmental Responsibility
    • Anti-Capital Punishment
  • Products
    • Inhaled Anaesthetics
      • Desflurane
      • Isoflurane
      • Sevoflurane
    • Injectable Anaesthesia and Pain Management
      • Hypnomidate® (Etomidate)
      • Rapifen® (Alfentanil Hydrochloride)
      • Rapifen® Intensive Care (Alfentanil Hydrochloride)
      • Sublimaze® (Fentanyl Citrate)
    • Type 1 Gaucher disease and Niemann-Pick Type C disease
    • Post Operative Pain Management
    • Animal Health
  • News & Events
  • Business Development
  • Contact & Support

Home / Products / Yargesa™ (Miglustat) / Summary of Product Characteristics and Patient Information Leaflet / MIG-UNITED KINGDOM-PatientInformationLeaflet-02

MIG-UNITED KINGDOM-PatientInformationLeaflet-02

MIG-UNITED KINGDOM-PatientInformationLeaflet-02

  • Piramal Group
    • Piramal Pharma Ltd.
    • Piramal Enterprises Ltd.
    • Piramal Realty
    • Piramal Foundation
  • About
    • Our Story
    • Management Team
    • Manufacturing Facilities
    • Careers
    • Corporate Responsibility
  • Products
  • Business Development
  • News & Events
© 2024 UK – Piramal Critical Care
  • Privacy Policy
  • Disclaimer